000 | 01956 a2200565 4500 | ||
---|---|---|---|
005 | 20250517142131.0 | ||
264 | 0 | _c20170424 | |
008 | 201704s 0 0 eng d | ||
022 | _a1520-4804 | ||
024 | 7 |
_a10.1021/acs.jmedchem.7b00124 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGopalsamy, Ariamala | |
245 | 0 | 0 |
_aDesign of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA). _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _c04 2017 |
||
300 |
_a3094-3108 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aEndoribonucleases _xantagonists & inhibitors |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aMuscular Atrophy, Spinal _xdrug therapy |
650 | 0 | 4 |
_aQuinazolines _xchemistry |
650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
650 | 0 | 4 | _aSurvival of Motor Neuron 2 Protein |
700 | 1 | _aNarayanan, Arjun | |
700 | 1 | _aLiu, Shenping | |
700 | 1 | _aParikh, Mihir D | |
700 | 1 | _aKyne, Robert E | |
700 | 1 | _aFadeyi, Olugbeminiyi | |
700 | 1 | _aTones, Michael A | |
700 | 1 | _aCherry, Jonathan J | |
700 | 1 | _aNabhan, Joseph F | |
700 | 1 | _aLaRosa, Gregory | |
700 | 1 | _aPetersen, Donna N | |
700 | 1 | _aMenard, Carol | |
700 | 1 | _aFoley, Timothy L | |
700 | 1 | _aNoell, Stephen | |
700 | 1 | _aRen, Yong | |
700 | 1 | _aLoria, Paula M | |
700 | 1 | _aMaglich-Goodwin, Jodi | |
700 | 1 | _aRong, Haojing | |
700 | 1 | _aJones, Lyn H | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 60 _gno. 7 _gp. 3094-3108 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.jmedchem.7b00124 _zAvailable from publisher's website |
999 |
_c26933043 _d26933043 |